Eaton Vance Management raised its position in Colgate-Palmolive Co. (NYSE:CL) by 0.2% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,621,986 shares of the company’s stock after buying an additional 3,973 shares during the period. Eaton Vance Management owned 0.18% of Colgate-Palmolive worth $118,729,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the company. State Street Corp raised its position in Colgate-Palmolive by 1.2% in the first quarter. State Street Corp now owns 62,333,093 shares of the company’s stock worth $4,403,835,000 after buying an additional 742,556 shares in the last quarter. Wellington Management Group LLP raised its position in Colgate-Palmolive by 22.2% in the first quarter. Wellington Management Group LLP now owns 41,060,286 shares of the company’s stock worth $2,900,908,000 after buying an additional 7,453,260 shares in the last quarter. BlackRock Fund Advisors raised its position in Colgate-Palmolive by 3.5% in the first quarter. BlackRock Fund Advisors now owns 12,314,096 shares of the company’s stock worth $869,991,000 after buying an additional 413,740 shares in the last quarter. Geode Capital Management LLC raised its position in Colgate-Palmolive by 1.4% in the first quarter. Geode Capital Management LLC now owns 7,235,633 shares of the company’s stock worth $510,171,000 after buying an additional 100,609 shares in the last quarter. Finally, BlackRock Group LTD raised its position in Colgate-Palmolive by 1.2% in the first quarter. BlackRock Group LTD now owns 6,963,653 shares of the company’s stock worth $491,981,000 after buying an additional 81,398 shares in the last quarter. Hedge funds and other institutional investors own 73.25% of the company’s stock.

Colgate-Palmolive Co. (NYSE:CL) traded up 0.39% during mid-day trading on Monday, reaching $72.24. 1,156,828 shares of the company’s stock traded hands. The firm has a market cap of $64.40 billion, a PE ratio of 46.52 and a beta of 0.59. Colgate-Palmolive Co. has a 1-year low of $61.40 and a 1-year high of $75.38. The firm has a 50 day moving average of $74.22 and a 200 day moving average of $71.91.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Thursday, July 28th. The company reported $0.70 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.69 by $0.01. The company earned $3.85 billion during the quarter, compared to analysts’ expectations of $3.86 billion. Colgate-Palmolive had a net margin of 9.04% and a return on equity of 1,980.28%. The business’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.70 earnings per share. Analysts forecast that Colgate-Palmolive Co. will post $2.79 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, November 15th. Investors of record on Monday, October 24th will be issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a yield of 2.17%. The ex-dividend date is Thursday, October 20th. Colgate-Palmolive’s payout ratio is 100.65%.

A number of research firms recently commented on CL. B. Riley reaffirmed a “neutral” rating and issued a $71.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, August 3rd. Goldman Sachs Group Inc. reaffirmed a “neutral” rating and issued a $76.00 price objective (up previously from $74.00) on shares of Colgate-Palmolive in a research note on Friday, July 15th. Atlantic Securities began coverage on shares of Colgate-Palmolive in a research note on Wednesday, June 1st. They issued an “overweight” rating for the company. BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research note on Friday, July 29th. Finally, JPMorgan Chase & Co. reaffirmed a “hold” rating and issued a $75.00 price objective on shares of Colgate-Palmolive in a research note on Friday, July 29th. Fourteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $74.46.

In related news, Director Stephen I. Sadove sold 8,803 shares of the stock in a transaction on Monday, August 8th. The shares were sold at an average price of $74.28, for a total transaction of $653,886.84. Following the completion of the transaction, the director now owns 26,474 shares in the company, valued at $1,966,488.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard J. Kogan sold 8,000 shares of the stock in a transaction on Wednesday, August 10th. The stock was sold at an average price of $74.66, for a total transaction of $597,280.00. Following the transaction, the director now owns 76,065 shares of the company’s stock, valued at approximately $5,679,012.90. The disclosure for this sale can be found here. Corporate insiders own 1.05% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.